BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3141053)

  • 1. Circadian variations of interferon-induced enhancement of human natural killer (NK) cell activity.
    Gatti G; Cavallo R; Sartori ML; Carignola R; Masera R; Delponte D; Salvadori A; Angeli A
    Cancer Detect Prev; 1988; 12(1-6):431-8. PubMed ID: 3141053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian changes in human natural killer-cell activity.
    Gatti G; Del Ponte D; Cavallo R; Sartori ML; Salvadori A; Carignola R; Carandente F; Angeli A
    Prog Clin Biol Res; 1987; 227A():399-409. PubMed ID: 3299388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered circadian rhythms of natural killer (NK) cell activity in patients with autoimmune rheumatic diseases.
    Masera RG; Carignola R; Staurenghi AH; Sartori ML; Lazzero A; Griot G; Angeli A
    Chronobiologia; 1994; 21(1-2):127-32. PubMed ID: 7924633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
    J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay in vitro between ACTH, beta-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity.
    Gatti G; Masera RG; Pallavicini L; Sartori ML; Staurenghi A; Orlandi F; Angeli A
    Brain Behav Immun; 1993 Mar; 7(1):16-28. PubMed ID: 8386029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming effects of interferon-beta ser on NK activity of peripheral blood mononuclear cells in cancer patients.
    Fujimiya Y; Wagner RJ; Groveman S; Sielaff K; Kohsaka T; Nakayama M
    Ther Immunol; 1995 Feb; 2(1):15-22. PubMed ID: 7553067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
    Okabe M; Gomi K; Morimoto M; Nakamizo N
    Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects.
    Lévi FA; Canon C; Touitou Y; Reinberg A; Mathé G
    J Clin Invest; 1988 Feb; 81(2):407-13. PubMed ID: 3257498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
    Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A
    Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The autocrine-paracrine modulation of natural killer activity in man by peptides of the corticostatin-defensin family].
    Masera RG; Gatti G; Bateman A; Solomon S; Sartori ML; Staurenghi A; Lazzero A; Griot G; Angeli A
    Ann Ital Med Int; 1993; 8(2):80-5. PubMed ID: 8353023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes caused by staphylococcal protein A and gamma interferon on the natural cytotoxic activity in patients with cancer].
    Subirá ML; Sánchez-Ibarrola A
    Rev Esp Fisiol; 1989; 45 Suppl():239-44. PubMed ID: 2518334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytes.
    Matera L; Cardoso E; Veglia F; Cesano A; Bellone G; Vuolo A; Molinatti GM
    J Clin Lab Immunol; 1988 Oct; 27(2):77-81. PubMed ID: 3266762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum.
    Lauer SJ; Finlan J; Borella LD; Piaskowski VD; Casper JT
    J Clin Lab Immunol; 1983 Oct; 12(2):105-10. PubMed ID: 6606047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
    Flexman JP; Shellam GR
    Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.